crazy, page-2

seanl, it is quite simple. The rise in the share price has happened because for the first time (certainly in the recent past) Benitec is getting exposure in the USA. American retail investors can see it is a bargain and they are piling in. They understand biotech better than Australian investors.

IMO, this has happened not because management has been over there trying to drum up interest - they have been doing that for years with little success. It is because a number of US stock forums have picked up on the stock at the same time and the timing of this has coincided with us about to enter the clinic with HCV.

If you look at the chatter on the US forums you will see a big increase in recent times followed by an increase in buying. Compare this to Oct/Nov when there was virtually no chatter and no trading.

The question now is, what do American retail investors think is a fair price for the company in its current situation?